iDeals：中国药企出海报告深入探究中国医药产业的全球扩张（英文版）（60页）.pdf

1、2Empower Biopharma InnovationAccelerate Decision-makingFounded in 2015,Pharmcube strives to reconstruct pharmaceutical data,bridge the information gap,and thoroughly empower innovation.By leveraging data across the full life-cycle of pharmaceutical products plus scalable and highly compatible Al tec

2、hnology,Pharmcube has successfully launched over ten enterprise-level data products,serving 1,000+leading pharmaceutical companies and investment institutions.We also provide you with media and consulting services that facilitate your strategic planning and decision-making and promote the innovation

3、 and transformation of the pharmaceutical industry.Our Industry InfluenceOur trustworthy data and constantly-improving service have won clients heart.We Are GrowingWe team up with top talents.Over 56%master or Ph.D holders,and more than 60%top university graduates(such as Peking University,Tsinghua

4、University,Fudan University or Shanghai Jiao Tong University),around 10%of them receive education in overseas universities.Our team of data specialists have not just experience but also the spirit to innovate.llLeading pharma companies and institutions choiceNextBiopharm-Timely,accurate and reliable

5、 intelligence on global new drugsIntroducing NextBiopharm,a cutting-edge database meticulously crafted and launched by Pharmcube,designed specifically to spotlight global new drugs with unparalleled coverage in the Chinese market.This platform seamlessly integrates and standardizes a wealth of infor

6、mation,including patents,literature,clinical trials,news,deals,and marketing data,providing a comprehensive overview of every novel molecule worldwide.As a proud member of the Pharmcube family,NextBiopharmTM is well linked with other offerings such as NextPat,PharmaGO,MedAlpha,etc.,ensuring a robust